China Molybdenum Co Ltd
OTC:CMCLF
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
0.5
1.09
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
China Molybdenum Co Ltd
Research & Development
China Molybdenum Co Ltd
Research & Development Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Research & Development | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
C
|
China Molybdenum Co Ltd
OTC:CMCLF
|
Research & Development
-¥331.5m
|
CAGR 3-Years
-23%
|
CAGR 5-Years
1%
|
CAGR 10-Years
N/A
|
|
|
Ganfeng Lithium Co Ltd
SZSE:002460
|
Research & Development
-¥994.3m
|
CAGR 3-Years
-56%
|
CAGR 5-Years
-68%
|
CAGR 10-Years
N/A
|
|
|
CMOC Group Ltd
SSE:603993
|
Research & Development
-¥331.5m
|
CAGR 3-Years
-23%
|
CAGR 5-Years
1%
|
CAGR 10-Years
N/A
|
|
|
Zhejiang Huayou Cobalt Co Ltd
SSE:603799
|
Research & Development
-¥1.4B
|
CAGR 3-Years
-37%
|
CAGR 5-Years
-38%
|
CAGR 10-Years
N/A
|
|
|
C
|
China Northern Rare Earth Group High-Tech Co Ltd
SSE:600111
|
Research & Development
-¥194m
|
CAGR 3-Years
-3%
|
CAGR 5-Years
-14%
|
CAGR 10-Years
N/A
|
|
|
Yintai Gold Co Ltd
SZSE:000975
|
Research & Development
-¥99.9m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
China Molybdenum Co Ltd
Glance View
In the world of mining and natural resources, China Molybdenum Co Ltd (CMOC) stands as a significant player, weaving a narrative of strategic global presence and diversification. Established in 1969 and listed on both the Hong Kong and Shanghai stock exchanges, the company has burgeoned into a noteworthy multinational, predominantly dealing with the exploration and trading of the mineral molybdenum, alongside other critical metals like tungsten, cobalt, and copper. With its headquarters nestled in Luoyang, Henan Province, China, CMOC has systematically expanded its portfolio through strategic acquisitions and partnerships. The audacious purchase of the Brazilian niobium and phosphate assets from Anglo American in 2016, and the acquisition of the Tenke Fungurume copper-cobalt mine in the Democratic Republic of Congo, underscore its ambitions and adept maneuvering in the global mining stage. CMOC's operational prowess extends across continents, transforming raw mineral deposits into tradable commodities, fueling global industries such as steel manufacturing and energy storage. The company garners revenue by mining mineral-rich ore bodies, processing these ores to produce valuable metals, and distributing them into both domestic and international markets. By leveraging its expertise, CMOC strategically positions itself amidst evolving technological demands and environmental considerations, making strides in sustainable mining practices. Through a mosaic of operational sites spread from Asia to South America and Africa, CMOC not only enriches its portfolio but invokes resiliency against commodity price fluctuations and geopolitical uncertainties. This diverse geographical reach and product mix enable CMOC to navigate the cyclical nature of the mining industry, setting the stage for continued growth and adaptability in an ever-evolving market.
See Also
What is China Molybdenum Co Ltd's Research & Development?
Research & Development
-331.5m
CNY
Based on the financial report for Sep 30, 2024, China Molybdenum Co Ltd's Research & Development amounts to -331.5m CNY.
What is China Molybdenum Co Ltd's Research & Development growth rate?
Research & Development CAGR 5Y
1%
Over the last year, the Research & Development growth was -14%. The average annual Research & Development growth rates for China Molybdenum Co Ltd have been -23% over the past three years , 1% over the past five years .
You don't have any saved screeners yet
